These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23348588)

  • 41. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.
    Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K
    Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
    Nahacka Z; Svadlenka J; Peterka M; Ksandrova M; Benesova S; Neuzil J; Andera L
    Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):522-531. PubMed ID: 29278689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TRADD is critical for resistance to TRAIL-induced cell death through NF-κB activation.
    Kim JY; Lee JY; Kim DG; Koo GB; Yu JW; Kim YS
    FEBS Lett; 2011 Jul; 585(14):2144-50. PubMed ID: 21627969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation.
    Ehrenschwender M; Siegmund D; Wicovsky A; Kracht M; Dittrich-Breiholz O; Spindler V; Waschke J; Kalthoff H; Trauzold A; Wajant H
    Cell Death Differ; 2010 Sep; 17(9):1435-47. PubMed ID: 20379197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of N-myc expression sensitizes human neuroblastoma IMR-32 cells expressing caspase-8 to TRAIL.
    Lee MW; Kim DS; Kim HR; Park HJ; Lee JW; Sung KW; Koo HH; Yoo KH
    Cell Prolif; 2019 May; 52(3):e12577. PubMed ID: 30724400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes.
    Zoller V; Funcke JB; Roos J; Dahlhaus M; Abd El Hay M; Holzmann K; Marienfeld R; Kietzmann T; Debatin KM; Wabitsch M; Fischer-Posovszky P
    Sci Rep; 2017 Jul; 7(1):5691. PubMed ID: 28720906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
    Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
    Sasaki H; Ohara N; Xu Q; Wang J; DeManno DA; Chwalisz K; Yoshida S; Maruo T
    J Clin Endocrinol Metab; 2007 Feb; 92(2):616-23. PubMed ID: 17105846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (FLS) by phosphorylation of Akt.
    Fujikawa K; Kawakami A; Tanaka F; Iwamoto N; Tamai M; Eguchi K
    Clin Exp Rheumatol; 2009; 27(6):952-7. PubMed ID: 20149311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation.
    Kim YH; Lee YJ
    J Cell Biochem; 2007 Mar; 100(4):998-1009. PubMed ID: 17031854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer.
    Huang M; Zhu H; Yi C; Yan J; Wei L; Yang X; Chen S; Huang Y
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):829-838. PubMed ID: 30167846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytoprotective effect of genistein against dexamethasone-induced pancreatic β-cell apoptosis.
    Suksri K; Semprasert N; Limjindaporn T; Yenchitsomanus PT; Kooptiwoot S; Kooptiwut S
    Sci Rep; 2022 Jul; 12(1):12950. PubMed ID: 35902739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways.
    Harsha Raj M; Yashaswini B; Rössler J; Salimath BP
    Apoptosis; 2016 May; 21(5):578-93. PubMed ID: 26921178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.
    Mazurek N; Byrd JC; Sun Y; Hafley M; Ramirez K; Burks J; Bresalier RS
    Cell Death Differ; 2012 Mar; 19(3):523-33. PubMed ID: 21941373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
    Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
    Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.
    Pespeni MH; Hodnett M; Abayasiriwardana KS; Roux J; Howard M; Broaddus VC; Pittet JF
    Cancer Res; 2007 Mar; 67(6):2865-71. PubMed ID: 17363610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caspase-8 regulation of TRAIL-mediated cell death.
    Crowder RN; El-Deiry WS
    Exp Oncol; 2012 Oct; 34(3):160-4. PubMed ID: 23070000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
    Lee YJ; Seol JW; Jeong JK; Moon MH; Park SY
    Mol Med Rep; 2011; 4(6):1255-9. PubMed ID: 21850375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.